Student graduation outcomes are shown here to provide stakeholders with the data regarding the retention and successes of the PharmD program.
KGI leverages close biotechnology and pharmaceutical industry ties to prepare doctors of pharmacy to fulfill a wide range of integral healthcare roles. Required and optional industry experiential education provides students with a breadth of hands-on training designed to enhance their skills and knowledge, while increasing their competitiveness in the job market.
KGI prepares student pharmacists for advances at the leading edge of pharmacy practice
Along with a PharmD degree, KGI graduates receive a certificate in one of four areas
Students complete rotations in community pharmacy, health-systems, senior adult chronic care, industry, and more
Professional standards, from the Accreditation Council on Pharmacy Education (ACPE), the Center for the Advancement of Pharmaceutical Education (CAPE) Outcomes and the North American Pharmacy Licensure Examination (NAPLEX) Blueprint, are the basis of the School of Pharmacy Program Outcomes. The program’s curricular outcomes are defined at a more general level by the Global Program Learning Outcomes, and more specifically as the Professional Student Outcomes. To learn more about the nine Global Program Learning Outcomes, visit kgi.edu/pharmd-gplo.
You can also learn more about the PharmD program by visiting our Class Profile page, Curriculum Four-Year Plan, and Curriculum Map.
* Current data represents any exams completed from May through August 2020. Additional NAPLEX results for the Class of 2020 will be reported in Spring 2021.
Source: California Board of Pharmacy
*Percentage of students admitted in 2014 who graduated in 2018
#Percentage of students admitted in 2015 who graduated in 2019
In 2018, SPHS graduated 66 students, 86% of whom responded to a series of surveys and other inquiries regarding post-graduation placements. Based on the survey results, 81% of the class reported being either employed in the profession or in the process of completing post-graduate pharmacy education. Two graduates were accepting into competitive post-graduate year 2 (PGY-2) pharmacy residencies in Oncology and Leadership. The results by percentage are indicated below.
At Commencement 2019, there were 75 PharmD graduates. Nearly all of the graduates indicated that they are pursuing registered pharmacist (RPh) licensure. Of the 75 graduates, 10 (13.3%) went on to pharmacy residency sites, and 8 (10.6%) were awarded fellowships. The remainder are looking for work pending licensure.